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A Commentary on
Commentary: Can Blood Flow Restricted Exercise Cause Muscle Damage? Commentary on
Blood Flow Restriction Exercise: Considerations of Methodology, Application, and Safety
by Wernbom, M., Schoenfeld, B. J., Paulsen, G., Bjørnsen, T., Cumming, K. T., Aagaard, P., et al.
(2020). Front. Physiol. 11:243. doi: 10.3389/fphys.2020.00243
Blood flow restricted (BFR) exercise is increasingly popular for rehabilitative and adjunct strength
training wherein the use of reduced loads may be beneficial (Slysz et al., 2015; Hughes et al., 2017).
A majority of peer-reviewed evidence appears to support the relative safety of BFR exercise in a
supervised research/rehabilitation setting. However, as with any exercise, there remains a possibility
of adverse outcomes, and the interference of normal blood flow patterns could potentially affect
this risk. While overwhelming data supports the vast majority of exercise to be beneficial for health,
vigorous physical activity can acutely increase the risk of a serious adverse event in susceptible
people (Franklin et al., 2020). In this context, we must be aware that the introduction of BFR can
make otherwise low-intensity exercise considerably more stressful; hence our unambiguous call
for careful screening of participants, and methodical progression of training volumes with specific
attention to those performing unaccustomed exercise (Patterson et al., 2019). We appreciate the
recently expressed opinion of Wernbom and colleagues on the risk of BFR (Wernbom et al., 2020),
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which in many ways reinforces our original perspective that
these potential risks of BFR training must be respected, without
assuming that the physiological response to BFR will be identical
to that of exercise in the absence of BFR. However, we feel that
their commentary fails to acknowledge that a majority of the
arguments they raise are indeed already reflected in our original
position stand- and that our original conclusions, which we stand
by, were based on a breadth of literature rather than select studies
that support any particular narrative.
In their editorial Wernbom and colleagues pose the question,
“Can Blood Flow Restricted Exercise Cause Muscle Damage?”
and we feel safe suggesting the consensus is “yes” it could.
In fact, we have highlighted existing evidence demonstrating
that rare adverse events have indeed occurred with BFR-RE
and it is important to note that such things can happen with
“traditional” exercise as well. We, thus, contend that it is the
likelihood of such events occurring, and the risk that they pose,
which is of greater concern to the current debate about the
risk of muscle damage. While our group holds that evidence
for an increased risk of a serious adverse event in the form
of rhabdomyolysis in a normal training environment remains
very low (0.07–0.2%) (Thompson et al., 2017; Patterson et al.,
2019), Wernbom and colleagues extrapolate from two studies
on unaccustomed subjects to suggest: “. . . the incidence rate of
rhabdomyolysis after acute BFR-RE would be as high as 22 and
67%,” and the rate of exercise-induced myopathy would be 33
and 100%.” Firstly, we wish to highlight that these estimates
are from studies with low subject numbers (Yasuda et al., 2015;
Sieljacks et al., 2016; both n≤ 10) and the apparently high rates in
these small studies are driven by only a few extreme responders.
In one of these studies, the evidence for rhabdomyolysis is
extrapolated from blood measures collected on only 3 subjects
(Yasuda et al., 2015). Taken out of context, it is perhaps difficult
to fully comprehend these disparate estimates of risk, which
exist at opposite ends of the spectrum. Despite their own initial
presentation of these statistics, we agree with Wernbom et al.
that these numbers cannot be taken to represent BFR in general-
and for a number of reasons, which we expand upon to follow-
these figures are misleading and support a counter-argument
to a point that our group is not attempting to make. Despite
taking a reductionist approach here for brevity of our response,
we wish to highlight that both group’s points are made with
respect to nuance and circumstance; and the possibility that
BFR related rhabdomyolysis could occur given the presence of
multiple pre-disposing factors, vs. the likelihood of it occurring
in a well-controlled setting, are perhaps very different arguments.
The largest discrepancy in this risk interpretation stems from
the definition of meaningful muscle damage, and subsequently
the occurrence of bona fide exertional rhabdomyolysis.
Exertional rhabdomyolysis is a serious, or even fatal, condition
associated with renal injury, and diagnosis depends on a
combination of clinical expertise and laboratory findings that
take into account participant pain, weakness, and muscle
swelling, combined with substantially elevated levels of creatine
kinase (CK) (Tietze and Borchers, 2014). Notably, our group
embraces this strict definition of rhabdomyolysis, which we
view as a serious adverse event, though we recognize that others
may classify this on more of a continuum, which would affect
the categorization of incidence. As Wernbom and colleagues
themselves recognize, CK is an indirect measure of damage,
and thus we suggest overreliance on this marker to interpret
risk could be problematic. Elevated circulating CK following
vigorous activity is common, and can occur in any individual
who exercises beyond his or her normal muscular capabilities,
often present in competitive athletes, deconditioned persons
pushed far beyond their limits, and military recruits (Randall
et al., 1996). Marathon runners, for example, demonstrate
increases in circulating CK up to 25 times baseline following
competition (Siegel et al., 1980); yet despite high CK, it is worth
noting that the need for medical intervention remains low.
Owing to the poorly defined cut-offs for laboratory values of CK,
various thresholds have been suggested; however, these must be
taken in context and applied judiciously. We suggest caution
in interpreting evidence that all CK values >10,000 U/L are
necessarily indicative of exertional rhabdomyolysis or that 2,000
U/L to be indicative of myothpathy as Wernbom and colleagues
suggest, given that the original references for these indicators
were not in the context of exercise, but rather considered renal
consequences of statin therapy (Clarkson et al., 2006). While we
can appreciate the desire to use an objective cut-off, we do not
believe the literature currently provides sufficiently supported
evidence of such ranges with specific reference to exertional
rhabdomyolysis, and it is worth noting that some individuals
could present with adverse responses at much higher or lower
levels than others, depending on individual factors including
hydration status, body mass, or renal function. As such, we
believe greater weight should presently be given to evidence of
actual adverse events, rather than a single risk factor/marker
about which there still exists substantial debate regarding
prognostic value.
Accepting that elevations in CK and rhabdomyolysis are
not synonymous, the original work that Wernbom and
colleagues highlight from their own group and others should be
commended, as it adds to our understanding of muscular stress
and potential for damage and adaptation interference during BFR
exercise training (Sieljacks et al., 2016; Bjørnsen et al., 2019).
While we did not cite some of this work in our earlier review
owing to it being released after our publication, these studies
clearly demonstrate the possible magnitude of CK changes
following BFR use. Given the large interindividual difference in
response to unaccustomed muscular work (Sieljacks et al., 2016),
we believe this data further supports our original conclusion that
certain individuals are more susceptible to muscular insult than
others, and the use of particularly challenging BFR exercise in
untrained participants demonstrates our point advocating for
tailored individualized progression. We have also highlighted the
fact that the well-accepted repeated bout effect, which protects
against muscular soreness and damage in subsequent challenging
exercise, appears to be applicable to BFR exercise in the same way
it is for non-occluded exercise. Wernbom and colleagues, in their
editorial, suggest BFR exercise led to greater muscle damage than
that which was observed following eccentric exercise (Sieljacks
et al., 2016). However, overall the indirect measures of muscle
damage were comparable between BFR and maximal eccentric
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exercise, a key finding acknowledged in the original study.
This suggests that the specific use of BFR exercise does not
necessarily magnify risk compared to a more traditional (non-
occluded) challenging exercise, which is an important benchmark
in understanding the risk of BFR in relation to muscle damage.
It is worth noting that in this specific study, BFR exercise was
performed to task failure, which we have acknowledged likely
increases the muscular stress of a given exercise bout and results
in muscular adaptations, but is not required for most people. In
fact, recently reported non-failure based BFR protocols from this
very group present similar results as failure protocols (Sieljacks
et al., 2019) which is in line with our recommendations. However,
even when an acute bout of BFR exercise is performed to task
failure, recent evidence would suggest that muscle damage is
similar to high-load resistance training, which is traditionally
recommended to promote neuromuscular adaptations (Alvarez
et al., 2020).
Despite the claim by Wernbom and colleagues that all of
the studies showing prominent alterations in CK/muscle damage
(Yasuda et al., 2015; Sieljacks et al., 2016; Bjørnsen et al., 2019)
were in line with the model of exercise prescription we suggest
(see Table 1 in Patterson et al., 2019), we feel this to be somewhat
disingenuous as participants in these studies were (by design) not
accommodated to resistance exercise and not prescribed exercise
in a progressive fashion. While these studies have adhered to
some individual components of the suggested guidelines, it is
worth noting that the combined prescription of cuff-pressure,
repetitions, sets, and daily/weekly exercise frequency should be
considered concurrently, as they are likely to interact. Prescribing
BFR exercises that exist on the high-end of more than one of
the recommended ranges across the exercise variables can make
the overall stress of any given prescription much more intensive.
As such, it is not surprising that this type of exercise would
be challenging for previously unaccustomed participants, and
the table recommendations must be considered in the overall
context of our paper and the explicit guidelines that suggest
an individually tailored, progressive approach. Even with these
intensive exercise protocols, the elevation of CK and markers of
muscular stress resulted in some expected perceived discomfort
and muscle damage but did not lead to conditions requiring
medical intervention. As the study investigators highlight, and as
we noted in our original text, previous training further attenuated
the rise in CK and other markers of muscle damage with a
repeated bout (Sieljacks et al., 2016); and less intensive loading
protocols resulted in a lesser response, thus supporting our
recommendation for careful prescription to mitigate risk.
Ultimately, we agree with Wernbom and colleagues that
BFR research remains in its infancy and further work
to understand the extent of physiological systems affected,
mechanisms of adaptation, and alterations in risk-stratification
are required. While isolated case-reports demonstrating adverse
reactions with the use of BFR exist in the literature, we
contend that this represents a very small proportion of
users, and many of the current cases can be explained
by predisposing factors, or improper exercise prescription.
Until a greater amount of objective risk-specific evidence
is available, there may be value in extrapolating potential
risk from more mechanistic studies, but we urge caution
in the interpretation of these surrogate measures, which
represent physiological stress, but not necessarily health risk.
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